secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2022-01-06T23:59:59+00:00
Accession:  0001683168-22-000135
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma files investor presentation; no new material details visible in exhibit text
--------------------------------------------------------------------------------

- Furnished investor presentation under Item 7.01 for virtual conferences on Jan 10-13, 2022.
- Presentation text provided in filing is truncated and contains only standard disclaimers.
- No specific financial results, guidance, or business updates can be extracted from available text.
- Filing does not contain any earnings release, M&A, leadership change, or other material event.
- Investors should refer to the full presentation if made available elsewhere for potential updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822000135/0001683168-22-000135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822000135/snoa_i8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-000135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer